In 2023, industry is witnessing a renaissance in viral vector characterization. Spurred by widespread biopharma investment to engineer a new wave of novel capsids and faced with newly launched QbD ...
Lentiviral-derived transfer vectors have gained increased attention because their karyophilic properties allow their use for the transduction of quiescent cells. 1, 2 The acceptance of their use in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback